"MAURITIUS": Tumour dose in patients with advanced carcinoma

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Virgolini, I ^a   Kurtaran, A ^a   Angelberger, P ^a   Raderer, M ^a   Havlik, E ^a   Smith Jones, P ^a  

^a NONE

Author keywords

Endocrine tumours; MAURITIUS; Somatostatin receptors

Indexed keywords

ANGIOPEPTIN; INDIUM 111; LIGAND; MAURITIUS IN 111; MAURITIUS Y 90; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TRACER; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; YTTRIUM 90;

ADVANCED CANCER; BINDING AFFINITY; BLOOD; BONE SCINTISCANNING; CANCER RADIOTHERAPY; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DOSIMETRY; FECES; HUMAN; LIVER METASTASIS; LYMPHOMA; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSTATE CANCER; RADIATION DOSE; RECTUM CANCER; SCINTIGRAPHY; URINE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; INDIUM RADIOISOTOPES; MALE; NEUROENDOCRINE TUMORS; PEPTIDES, CYCLIC; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032700747     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-9.
2. 111In-DTPA-D-Phe-1-OCT. Eur J Nucl Med 1996;23:1388-99.
3. 99m-labelled somatostatin receptor binding peptides. J Nucl Med 1996;36:1016-22.
4. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, et al. Vasoactive intestinal peptide (VIP) receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumours. N Engl J Med 1994;331:1116-21.
5. Virgolini I, Kurtaran A, Raderer M, Leimer M, Angelberger P, Havlik E, et al. Vasoactive intestinal peptide receptor scintigraphy. J Nucl Med 1995;36:1732-9,
6. 111-CYT-103 immunoscintigraphy. J Nucl Med 1996;37:1480-7.
7. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA 1992;89:251-5.
8. Yasuda K, Res-Domiano S, Breder CA, Law SF, Saper C, Reisine T, et al. Cloning of a novel somatostatin receptor, SST, coupled to adenylate cyclase. J Biol Chem 1992;267:20422-8.
9. Virgolini I, Pangeri T, Bischof C, Smith-Jones P, Peck-Radosavljevic M. Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer? Eur J Clin Invest 1997;27:645-7.
10. Smith-Jones P, Bischof C, Leimer M, Gludovacz D, Angelberger P, Pangeri T, et al. MAURITIUS: novel tumor diagnostic and therapeutic somatostatin analog. (In press).
11. 90Y-MAURITIUS: Successful treatment of a patient with advanced gastrinoma. J Nucl Med (In press).